KPNA4 and breast cancer: Our findings suggest that miR-567 could act as an oncogene, as its downregulation decreases cell proliferation in poor prognosis BC, increasing expression level of KPNA4. miR-567 might serve as a novel biomarker in the prognosis of BC and could be a regulator of KPNA4 expression.